Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Results for
"[search-keyword]"
Sponsor content
340 result(s) found, displaying 231 to 240
-
Prescription medicine registrationActive ingredients: ertugliflozin.
-
Prescription medicine registrationActive ingredients: ertugliflozin and sitagliptin phosphate monohydrate.
-
Prescription medicine registrationActive ingredients: ertugliflozin and metformin hydrochloride.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms/0.5mL, suspension for injection, syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms / 0.5mL, suspension for injection, vial.
-
Designation or determinationPriority review
-
Prescription medicine registrationActive ingredients: ezetimibe.
-
Prescription medicine registrationActive ingredients: pembrolizumab (rch).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NOXAFIL posaconazole 300 mg/16.7 mL concentrated injection vial.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd